연구성과로 돌아가기

2022 연구성과별 연구자 정보 (487 / 2879)

※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
Document Title Author Full Name Author Short Name Index Corresponding Address ResearcherID ResearcherID Author Name ORCID ORCID Author Name Related Email
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Jung, Sung-Ae Jung, SA 8 Ewha Womans Univ, Dept Gastroenterol, Coll Med, Seoul, South Korea 0000-0001-7224-2867 Jung, Sung-Ae gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Lee, Jun Lee, J 9 Chosun Univ, Dept Internal Med, Coll Med, Gwangju, South Korea AAC-6941-2022 Lee, Jun 0000-0002-8060-9646 Lee, Jun gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kang, Sang-Bum Kang, SB 10 Catholic Univ Korea, Dept Internal Med, Daejeon St Marys Hosp, Coll Med, Daejeon, South Korea AAG-4341-2021 Kwak, Sang Gyu 0000-0002-1946-7896 Kang, Sang-Bum gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Shin, Sung Jae Shin, SJ 11 Ajou Univ, Dept Gastroenterol, Sch Med, Suwon, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Eun Sun Kim, ES 12 Korea Univ, Dept Gastroenterol, Anam Hosp, Seoul, South Korea AAJ-7528-2021 Kim, Hanjun 0000-0003-1820-459X Kim, Eun Sun gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, You Sun Kim, YS 13 Inje Univ, Dept Gastroenterol, Seoul Paik Hosp, Seoul, South Korea B-2881-2015 Kim, You Sun gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Tae Oh Kim, TO 14 Inje Univ, Dept Gastroenterol, Haeundae Paik Hosp, Busan, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Hyun-Soo Kim, HS 15 Chonnam Natl Univ Hosp, Dept Gastroenterol, Gwangju, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Park, Dong Il Park, DI 16 Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Internal Med, Sch Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Hyung Kil Kim, HK 17 Inha Univ Hosp, Dept Gastroenterol, Incheon, South Korea J-5451-2012 Kim, Hyung gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Eun Soo Kim, ES 18 Kyungpook Natl Univ, Sch Med, Dept Internal Med, Korea, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Young-Ho Kim, YH 19 Sungkyunkwan Univ, Samsung Med Ctr, Dept Internal Med, Sch Med, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Do Hyun Kim, DH 20 AbbVie Ltd, Seoul, South Korea gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Teng, Dennis Teng, D 21 AbbVie Pte Ltd, Singapore, Singapore gicch@cau.ac.kr;
Clinical outcomes and predictors of response for adalimumab in patients with moderately to severely active ulcerative colitis: a KASID prospective multicenter cohort study Kim, Jong-Hwa Kim, JH 22 Chung Ang Univ, Dept Microbiol, Coll Med, Seoul, South Korea AHA-6528-2022 Kim, Jong-Hwa 0000-0002-3343-4820 Kim, Jong-Hwa gicch@cau.ac.kr;
페이지 이동: